HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Construction and expression of anti-CD3/anti-prostate-cancer bispecific single-chain antibody].

AbstractOBJECTIVE:
To construct a recombinant vector that expresses anti-CD 3/anti-prostate-cancer bispecific single-chain antibody (BsAb), and study its biological activities and clinical significance.
METHODS:
An anti-CD 3/anti-prostate-cancer BsAb was constructed by PCR and molecular biological technique of DNA cloning. The fusion gene, confirmed by sequencing, was subcloned into the pSectag2-B plasmid from the pUC18 vector by digestion with EcoR I and Hind III restriction endonucleases, whose sites exist in both the vectors. Then the recombinant plasmid was transfected into HeLa cells. The expression products in the supernatant were analyzed by both SDS-PAGE and Western blot technique, then were purified with Ni(2+)-NTA superflow affinity chromatography. Its biological activities were examined by flow cytometry (FCM).
RESULTS:
A fragment of 1.5 kb was inserted into the pUC18 vector, which was sequenced and verified to be identical with that designed. The expression of anti-CD 3 x anti-prostate-cancer BsAb yielded a soluble protein with an apparent molecular mass of 61 KD. The purification rate of the expressed BsAb was up to 90.537% and the yield of purified BsAb from this procedure was 0.09 mg/ml. The positive binding rates of BsAb to PBMC and to PC-3 cell were 54.1% and 53.7% respectively.
CONCLUSION:
The anti-CD 3 x anti-prostate-cancer BsAb thus constructed exhibits beneficial biological activities and may play an important role in the treatment of prostate cancer.
AuthorsDong Wang, Guo-jun Wu, He Wang, Shun-liang Yang, Wei-zhen Wu, Ting-zhao Xu, Jian-ming Tan
JournalZhonghua yi xue za zhi (Zhonghua Yi Xue Za Zhi) Vol. 83 Issue 15 Pg. 1292-5 (Aug 10 2003) ISSN: 0376-2491 [Print] China
PMID12930679 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Bispecific
  • Antibodies, Neoplasm
  • CD3 Complex
  • Recombinant Fusion Proteins
  • Prostate-Specific Antigen
Topics
  • Antibodies, Bispecific (biosynthesis, isolation & purification, therapeutic use)
  • Antibodies, Neoplasm (biosynthesis)
  • CD3 Complex (immunology)
  • Escherichia coli (genetics)
  • HeLa Cells
  • Humans
  • Male
  • Prostate-Specific Antigen (immunology, isolation & purification, therapeutic use)
  • Prostatic Neoplasms (immunology, therapy)
  • Recombinant Fusion Proteins (biosynthesis)
  • T-Lymphocytes (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: